Jill Sindt
( out of 133 reviews )

Jill Sindt, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Supportive Oncology and Survivorship
Salt Lake City
801-213-4246

Pain Management Center

Salt Lake City
801-581-7246

  • Dr. Sindt specializes in pain medicine and is skilled in procedural, medication and non-medication therapies for pain management. She has particular interest in cancer pain and practices both at the University of Utah Pain Management Center and at the Supportive Oncology and Survivorship clinic at Huntsman Cancer Hosptial.

    Specialties

    Board Certification

    American Board of Anesthesiology
    American Board of Anesthesiology (Sub: Pain Medicine)
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 133 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    December 27, 2024
    HUNTSMAN CANCER CENTER

    Dr Sindt is an excellent doctor. She works hands on with patients, their illness and treatments for pain. She is aware of everything going on with patients. Dr Sindt helps us understand risks of medications, side effects, what to expect and helps us understand changes. She and her staff are always available to help resolve questions.

    November 06, 2024
    PAIN MANAGEMENT CENTER

    I appreciate what a good listener Dr. Sindt is and how patiently she has explained the procedure and after-care. She is very "approachable". Thank you.

    October 10, 2024
    PAIN MANAGEMENT CENTER

    i feel completely confident in the care of dr. sindt. she is easy to ask questions to and clear in the answers she gives. she has a wonderful demenor.

    September 15, 2024
    HUNTSMAN CANCER CENTER

    Dr Sindt listen to my issues and was very helpful in trying to help me with my pain. She explained why I was getting the medication that I was getting and what to expect for side effects.

    September 14, 2024
    HUNTSMAN CANCER CENTER

    Dr. Sindt is going wonderful!

    September 09, 2024
    PAIN MANAGEMENT CENTER

    She's very friendly and helpful. She is well educated and knowledgeable on the surgery I needed done.

    July 17, 2024
    PAIN MANAGEMENT CENTER

    Wonderful Dr. Would Not Consider Seeing Anyone Else.

    June 07, 2024
    HUNTSMAN CANCER CENTER

    I messed up in one of my first responses. I touched a negative response, whereas everyone was outstanding. Sorry.

    June 05, 2024
    PAIN MANAGEMENT CENTER

    She was great very friendly, informative and listened to me and i felt very much like I was her only patient. I look forward to her treating me and my issues.

    See More Patient Comments

  • Dr. Sindt specializes in pain medicine and is skilled in procedural, medication and non-medication therapies for pain management. She has particular interest in cancer pain and practices both at the University of Utah Pain Management Center and at the Supportive Oncology and Survivorship clinic at Huntsman Cancer Hosptial.

    Board Certification and Academic Information

    Academic Departments Anesthesiology -Primary
    Board Certification
    American Board of Anesthesiology
    American Board of Anesthesiology (Sub: Pain Medicine)
    National Board of Medical Examiners

    Education history

    Fellowship Pain Medicine - University of Utah Fellow
    Chief Resident University of Utah Chief Resident
    Residency Anesthesiology - University of Utah Resident
    Internship Intermountain Medical Center Transitional Transitional Internship
    Research Fellow NIH Summer Research Fellowship in Pediatric Nutrition: the effects of a high-protein, low-carbohydrate diet on weight , lipid profiles, insulin profiles and satiety in obese adolescents. - University of Colorado Health Sciences Center, School of Medicine Research Fellow
    Professional Medical Medicine - University of Colorado School of Medicine M.D.
    Undergraduate Spanish Language and Literature, Summa Cum Laude - Colorado State University B.A.

    Selected Publications

    Journal Article

    1. Sindt JE, Fitzgerald LA, Kuznicki J, Prelewicz S, Odell DW, Brogan SE (2023). Antiplatelet and Wound Healing Implications of Immunotherapy and Targeted Cancer Therapies in the Perioperative Period. Anesthesiology, 139(4), 511-522. (Read full article)
    2. Brogan SE, Odell DW, Sindt JE, Yi I, Chrisman OM, Zhang C, Presson AP (2022). Dorsal Versus Ventral Intrathecal Catheter Tip Location and Effect on Dose Escalation and Opioid Use in Patients With Cancer Pain. Neuromodulation, 26(6), 1233-1239. (Read full article)
    3. Brogan SE, Sindt JE, Odell DW, Gulati A, Dupoiron D (2022). Controversies in intrathecal drug delivery for cancer pain. Reg Anesth Pain Med, 48(6), 319-325. (Read full article)
    4. Jenkinson RH, Wendahl A, Zhang Y, Sindt JE (2023). Creating Realistic Definitions of Clinically Significant Radiographic Lead Migration - A Response to "Migration of Epidural Leads During Spinal Cord Stimulator Trials" [Response to Letter]. J Pain Res, 16, 513-514. (Read full article)
    5. Jenkinson RH, Wendahl A, Zhang Y, Sindt JE (2022). Migration of Epidural Leads During Spinal Cord Stimulator Trials. J Pain Res, 15, 2999-3005. (Read full article)
    6. Sindt JE, Odell DW, Tariq R, Presson AP, Zhang C, Brogan SE (2021). Initial Intrathecal Dose Titration and Predictors of Early Dose Escalation in Patients With Cancer Using a 100:1 Oral to Intrathecal Morphine Conversion Ratio. Neuromodulation, 24(7), 1157-1166. (Read full article)
    7. Brogan SESindt JE, Odell DW (2021). Quantitative Assessment of the Incidence of Persistent Orthostatic Hemodynamic Changes After Celiac Plexus Neurolysis: A Prospective Case Series. A A Pract, 15(5), e01470.
    8. Brogan SE, Sindt JE, Odell DW (2021). Quantitative Assessment of the Incidence of Persistent Orthostatic Hemodynamic Changes After Celiac Plexus Neurolysis: A Prospective Case Series. A A Pract, 15(5), e01470. (Read full article)
    9. Odell DW, Albrechtsen RD, Sindt JE, Gole R, Brown S, Parsons MW, Paxton AB, Sarkar V, Lloyd S, Brogan SE, Tao R (2021). The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function. Neuromodulation, 24(7), 1204-1208. (Read full article)
    10. Sindt JE, Odell DW, Dalley AP, Brogan SE (2020). Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer. Neuromodulation, 23(7), 978-983.
    11. Sindt JE, Odell DW, Dalley AP, Brogan SE (2020). Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer. Neuromodulation, 23(7), 978-983. (Read full article)
    12. Sindt JE, Larsen SD, Dalley AP, Collier WH, Brogan SE (2020). The Rate of Infectious Complications After Intrathecal Drug Delivery System Implant for Cancer-Related Pain Is Low Despite Frequent Concurrent Anticancer Treatment or Leukopenia. Anesth Analg, 131(1), 280-287.
    13. Sindt JE, Larsen SD, Dalley AP, Collier WH, Brogan SE (2020). The Rate of Infectious Complications After Intrathecal Drug Delivery System Implant for Cancer-Related Pain Is Low Despite Frequent Concurrent Anticancer Treatment or Leukopenia. Anesth Analg, 131(1), 280-287. (Read full article)
    14. Brogan SE, Sindt JE, Jackman CM, White J, Wilding V, Okifuji A (2020). Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy. Anesth Analg, 130(4), 1035-1044.
    15. Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S, BCPS, OConnor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA (2019). Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(8), 977-1007. (Read full article)
    16. Iacob E, Hagn EE, Sindt J, Brogan S, Tadler SC, Kennington KS, Hare BD, Bokat CE, Donaldson GW, Okifuji A, Junkins SR (2017). Tertiary Care Clinical Experience with Intravenous Lidocaine Infusions for the Treatment of Chronic Pain. Pain Med, 19(6), 1245-1253. (Read full article)
    17. Sindt JE, Brogan SE (2016). Interventional Treatments of Cancer Pain. Anesthesiol Clin, 34(2), 317-39. (Read full article)
    18. Sindt J (2016). Managing Pain Before It Manages You. J Pain Palliat Care Pharmacother, 30(2), 155. (Read full article)

    Letter

    1. Abdullah N, Sindt JE, Whittle J, Anderson JS, Odell DW, Mahan M, Brogan SE (2022). Impact of neuromodulation on opioid use, adjunct medication use, and pain control in cancer-related pain: a retrospective case series. [Letter to the editor]. Pain Med, 24(7), 903-906. (Read full article)